← FDA Drug Approvals (Drugs@FDA)

RESTASIS

NDA · New Drug Application · Sponsor: ALLERGAN · Approved 2003-10-10

Drug application

FDA Application #

NDA021023

Application type

New Drug Application

Brand name

RESTASIS

Generic name

Cyclosporine

Active ingredients

CYCLOSPORINE

Dosage form

EMULSION

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

ALLERGAN

First approval

2003-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown